Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 437 | 3 | ANTIMICROBIAL PEPTIDE//GENE DELIVERY//CELL PENETRATING PEPTIDE | 28289 |
| 480 | 2 | GENE DELIVERY//CATIONIC LIPID//NON VIRAL VECTOR | 16009 |
| 20732 | 1 | MOL DESIGN PHARMACEUT//MULTIFUNCTIONAL ENVELOPE TYPE NANO DEVICE//MRNA DELIVERY | 472 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | MOL DESIGN PHARMACEUT | address | 1155612 | 10% | 38% | 45 |
| 2 | MULTIFUNCTIONAL ENVELOPE TYPE NANO DEVICE | authKW | 715405 | 3% | 71% | 15 |
| 3 | MRNA DELIVERY | authKW | 445139 | 2% | 67% | 10 |
| 4 | MRNA VACCINE | authKW | 427337 | 2% | 80% | 8 |
| 5 | INNOVAT NANOMED | address | 365195 | 4% | 29% | 19 |
| 6 | MULTIFUNCTIONAL ENVELOPE TYPE NANO DEVICE MEND | authKW | 297433 | 1% | 64% | 7 |
| 7 | PROGRAMMED PACKAGING | authKW | 213668 | 1% | 80% | 4 |
| 8 | PH SENSITIVE CATIONIC LIPID | authKW | 200316 | 1% | 100% | 3 |
| 9 | RIBOL | address | 200316 | 1% | 100% | 3 |
| 10 | RNACTIVE | authKW | 200316 | 1% | 100% | 3 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Medicine, Research & Experimental | 1626 | 23% | 0% | 107 |
| 2 | Pharmacology & Pharmacy | 1003 | 28% | 0% | 133 |
| 3 | Materials Science, Biomaterials | 926 | 8% | 0% | 36 |
| 4 | Biotechnology & Applied Microbiology | 684 | 17% | 0% | 81 |
| 5 | Chemistry, Multidisciplinary | 441 | 22% | 0% | 103 |
| 6 | Genetics & Heredity | 366 | 13% | 0% | 60 |
| 7 | Nanoscience & Nanotechnology | 346 | 10% | 0% | 48 |
| 8 | Immunology | 258 | 13% | 0% | 60 |
| 9 | Engineering, Biomedical | 201 | 6% | 0% | 27 |
| 10 | Multidisciplinary Sciences | 138 | 3% | 0% | 15 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | MOL DESIGN PHARMACEUT | 1155612 | 10% | 38% | 45 |
| 2 | INNOVAT NANOMED | 365195 | 4% | 29% | 19 |
| 3 | RIBOL | 200316 | 1% | 100% | 3 |
| 4 | TRANSLAT GENOM GENE THER Y | 150235 | 1% | 75% | 3 |
| 5 | MOL IMMUNOL EXPT ONCOL | 137840 | 2% | 26% | 8 |
| 6 | FUKUOKA DEV TECH GRP | 133544 | 0% | 100% | 2 |
| 7 | TRANSLAT EXPT ONCOL | 119229 | 1% | 36% | 5 |
| 8 | TRANSLAT ONCOL IMMUNOL TRON | 89028 | 0% | 67% | 2 |
| 9 | TRON TRANSLAT ONCOL | 83779 | 2% | 16% | 8 |
| 10 | ADVANCED LIFE SCI | 66772 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | JOURNAL OF CONTROLLED RELEASE | 14503 | 9% | 1% | 41 |
| 2 | MOLECULAR THERAPY-NUCLEIC ACIDS | 14465 | 2% | 2% | 10 |
| 3 | MOLECULAR THERAPY | 14209 | 6% | 1% | 28 |
| 4 | ADVANCES IN GENETICS | 4746 | 1% | 1% | 5 |
| 5 | PROGRESS IN TUMOR RESEARCH | 2301 | 0% | 3% | 1 |
| 6 | NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE | 2207 | 1% | 0% | 7 |
| 7 | GENE THERAPY | 2023 | 2% | 0% | 11 |
| 8 | ADVANCED HEALTHCARE MATERIALS | 1922 | 1% | 0% | 6 |
| 9 | BIOMATERIALS | 1727 | 4% | 0% | 20 |
| 10 | MOLECULAR PHARMACEUTICS | 1597 | 2% | 0% | 9 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |